- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Southard leaves Elscint's U.S. unit
Donald Southard has left his position as vice president of salesand marketing at Elscint's U.S. subsidiary in Hackensack, NJ,for a position at cardiac monitoring firm Datascope. Southard'sdeparture was amicable, according to Dr. Thomas Spackman,
Donald Southard has left his position as vice president of salesand marketing at Elscint's U.S. subsidiary in Hackensack, NJ,for a position at cardiac monitoring firm Datascope. Southard'sdeparture was amicable, according to Dr. Thomas Spackman, presidentof the subsidiary.
"Don was terrific," Spackman said. "He broughtimagination, direction, enthusiasm, and fun to Elscint."
Southard joined Elscint in 1994 after serving as presidentand CEO of independent service provider Serviscope. He has alsoworked for OEMs Philips and Toshiba. Spackman has taken over Southard'sresponsibilities temporarily, while Elscint undergoes a reviewof its corporate organization that may result in changes to thesubsidiary's executive lineup, Spackman said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
